Evidence map›Paper›PMID 30627818›Full record

ArticleHuman genetics2019

Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome.

Anelisa Gollo Dantas, Marcos Leite Santoro, Natalia Nunes, Claudia Berlim de Mello, Larissa Salustiano Evangelista Pimenta, Vera Ayres Meloni, Diogo Cordeiro Queiroz Soares, Sintia Nogueira Belangero, Gianna Carvalheira, Chong Ae Kim and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. ThePlant physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anelisa Gollo DantasGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-0594-6762
Marcos Leite SantoroInterdisciplinary Laboratory of Clinical Neurosciences (LiNC), Psychiatry Department, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-5714-9509
Natalia NunesGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-7247-4745
Claudia Berlim de MelloPsychobiology Department, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-3953-3966
Larissa Salustiano Evangelista PimentaGenetics Department, Instituto da Criança, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-5235-7851
Vera Ayres MeloniGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-4954-8766
Diogo Cordeiro Queiroz SoaresGenetics Department, Instituto da Criança, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-1279-9302
Sintia Nogueira BelangeroGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-2419-4351
Gianna CarvalheiraGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-6602-8319
Chong Ae KimGenetics Department, Instituto da Criança, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-1754-1300
Maria Isabel MelaragnoGenetics Division, Universidade Federal de São Paulo, São Paulo, Brazil. melaragno.maria@unifesp.br.ORCID http://orcid.org/0000-0002-4344-9698
Universidade Federal de São Paulo · BRUniversidade de São Paulo · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/11572-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/26768-5
6 · The paper itself

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) is caused by recurrent hemizygous deletions of chromosome 22q11.2. The phenotype of the syndrome is complex and varies widely among individuals. Little is known about the role of the different genes located in 22q11.2, and we hypothesized that genetic risk factors lying elsewhere in the genome might contribute to the phenotype. Here, we present the whole-genome gene expression data of 11 patients with approximately 3 Mb deletions. Apart from the hemizygous genes mapped to the 22q11.2 region, the TUBA8 and GNAZ genes, neighboring the deleted interval but in normal copy number, showed altered expression. When genes mapped to other chromosomes were considered in the gene expression analysis, a genome-wide dysregulation was observed, with increased or decreased expression levels. The enriched pathways of these genes were related to immune response, a deficiency that is frequently observed in 22q11.2DS patients. We also used the hypothesis-free weighted gene co-expression network analysis (WGCNA), which revealed the co-expression gene network modules with clear connection to mechanisms associated with 22q11.2DS such as immune response and schizophrenia. These findings, combined with the traditional gene expression profile, can be used for the identification of potential pathways and genes not previously considered to be related to the 22q11.2 deletion syndrome.

Indexed as

Chromosome DeletionBiomarkersCase-Control StudiesChromosomes, Human, Pair 22DiGeorge SyndromeDown-RegulationFollow-Up StudiesGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksGTP-Binding Protein alpha SubunitsHumansPhenotypePrognosisTubulinBiomarkersGNAZ protein, humanGTP-Binding Protein alpha SubunitsTUBA8 protein, humanTubulin

Identifiers

PMID30627818
OpenAlexW2910478987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.